
Meet Courtney
“Throughout my life, my hemophilia A has been dismissed, and I haven’t always received the care I needed. My mom decided to have a prenatal test when she was pregnant with me after my older brother, Derek, was diagnosed with hemophilia during his birth. She learned that I was a carrier for hemophilia, but I didn’t receive a diagnosis for mild hemophilia until I was 10. Even then, the doctor said, 'She’s female, so she’s only going to need factor for surgeries and childbirth, or if she ever gets injured or in a major car accident.'
However, it didn’t feel that mild when I got my period a couple years later; it lasted 2 weeks and I kept bleeding through my shorts. Or when I competed in cheer and dance, and a sprained ankle required on-demand treatment. When preparing for the birth of each of my 3 children, I made a plan with my doctor so we would be prepared during and all through recovery.
But still my factor levels weren’t where they needed to be. That’s when my brother told me about ALTUVIIIO. I learned that ALTUVIIIO was shown to offer higher-for-longer factor levels in the near-normal to normal range, over 40%, for most of the week in adults. It also showed a 48-hour half-life in adults. I asked my hematologist about ALTUVIIIO, and he agreed I should give it a try. I started taking ALTUVIIIO prophylactically in May of 2023.
My hope is that as awareness of hemophilia increases, more people will learn about how it can impact women as well as men, and can have significant consequences if not treated properly. I am grateful I live in a time where there is a treatment available to me.”
Courtney is a promotional speaker compensated by Sanofi. Peer stories based on data collected March 2026.
Get an overview of all the Peers in our network here!
Sign up for the Peer Mentor Program
Connect with a real ALTUVIIIO patient or caregiver for advice, information about their
experience, and more.
Hear from more patients

A college student who has been on ALTUVIIIO prophylaxis since July 2023.

An opera singer who switched from an EHL to ALTUVIIIO prophylaxis in June 2023.

Derek and Brooklynn are a father and daughter living with hemophilia and on ALTUVIIIO prophylaxis.
ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Your healthcare provider may give you ALTUVIIIO when you have surgery.
What is the most important information I need to know about ALTUVIIIO?
Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.
Who should not use ALTUVIIIO?
You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.
What should I tell my healthcare provider before using ALTUVIIIO?
Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.
What are the possible side effects of ALTUVIIIO?
You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.
The common side effects of ALTUVIIIO are headache and joint pain.
These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.
Please see full Prescribing Information.
Learn more about Sanofi’s commitment to fighting counterfeit drugs.
![ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/.imaging/default/dam/Marketing/AltuviiioUS/altuviiio.webp/jcr:content.webp)